LOIM
BEAM icon

Liberty One Investment Management’s Beam Therapeutics BEAM Stock Holding History

Liberty One Investment Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-87
Closed -$2.13K – 153
2024
Q3 		$2.13K Sell
87
-491
-85% -$12.7K ﹤0.01% 174
2024
Q2 		$14K Sell
578
-20
-3% -$491 ﹤0.01% 173
2024
Q1 		$19.8K Buy
598
+11
+2% +$343 ﹤0.01% 165
2023
Q4 		$16K Buy
587
+317
+117% +$7.87K ﹤0.01% 161
2023
Q3 		$6.49K Buy
270
+40
+17% +$1.07K ﹤0.01% 150
2023
Q2 		$7.34K Hold
230
– – ﹤0.01% 152
2023
Q1 		$7.04K Buy
+230
New +$9.08K ﹤0.01% 165
2022
Q2 		– Sell
-21
Closed -$1K – 138
2022
Q1 		$1K Buy
+21
New +$1.38K ﹤0.01% 151

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Liberty One Investment Management's BEAM Position: Q4 2024 in Review

Liberty One Investment Management sold out of Beam Therapeutics (BEAM) in Q4 2024, closing a stake of 87 shares — an estimated $2.13K sold.

Liberty One Investment Management first reported a position in BEAM in Q1 2022 and held it in 8 quarters. The position peaked at $19.8K in Q1 2024. 231 funds tracked by Wall St. Rank hold BEAM as of Q4 2024.

  • Liberty One Investment Management reported no remaining Beam Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Liberty One Investment Management sold 87 Beam Therapeutics shares in Q4 2024, an estimated $2.13K.
  • Liberty One Investment Management first reported a position in Beam Therapeutics in Q1 2022 and held it in 8 quarters.
  • Liberty One Investment Management's Beam Therapeutics position peaked at $19.8K in Q1 2024.
  • 231 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2024.

Based on Liberty One Investment Management's 13F filing for Q4 2024, filed 16 Jan 2025.